AUPR750601A0 - Peptide compounds - Google Patents

Peptide compounds

Info

Publication number
AUPR750601A0
AUPR750601A0 AUPR7506A AUPR750601A AUPR750601A0 AU PR750601 A0 AUPR750601 A0 AU PR750601A0 AU PR7506 A AUPR7506 A AU PR7506A AU PR750601 A AUPR750601 A AU PR750601A AU PR750601 A0 AUPR750601 A0 AU PR750601A0
Authority
AU
Australia
Prior art keywords
peptide compounds
peptide
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR7506A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPR7506A priority Critical patent/AUPR750601A0/en
Publication of AUPR750601A0 publication Critical patent/AUPR750601A0/en
Priority to US10/250,444 priority patent/US7129243B2/en
Priority to PCT/JP2001/011067 priority patent/WO2002055541A2/en
Priority to CNA018229107A priority patent/CN1531546A/en
Priority to DE60130922T priority patent/DE60130922T2/en
Priority to EP01273184A priority patent/EP1347990B1/en
Priority to IL15671101A priority patent/IL156711A0/en
Priority to CZ20032101A priority patent/CZ20032101A3/en
Priority to NZ527189A priority patent/NZ527189A/en
Priority to MXPA03005994A priority patent/MXPA03005994A/en
Priority to RU2003124057/04A priority patent/RU2281955C2/en
Priority to BR0116778-2A priority patent/BR0116778A/en
Priority to KR10-2003-7008426A priority patent/KR20030066745A/en
Priority to HU0302535A priority patent/HUP0302535A3/en
Priority to ES01273184T priority patent/ES2291275T3/en
Priority to JP2002556609A priority patent/JP4032179B2/en
Priority to AT01273184T priority patent/ATE375360T1/en
Priority to CA2433582A priority patent/CA2433582C/en
Priority to PL01366425A priority patent/PL366425A1/en
Priority to ARP010106106A priority patent/AR034012A1/en
Priority to NO20032963A priority patent/NO20032963L/en
Priority to ZA2003/05888A priority patent/ZA200305888B/en
Abandoned legal-status Critical Current

Links

AUPR7506A 2001-01-02 2001-09-05 Peptide compounds Abandoned AUPR750601A0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
AUPR7506A AUPR750601A0 (en) 2001-09-05 2001-09-05 Peptide compounds
PL01366425A PL366425A1 (en) 2001-01-02 2001-12-18 Peptide compounds
RU2003124057/04A RU2281955C2 (en) 2001-01-02 2001-12-18 Peptide compounds
KR10-2003-7008426A KR20030066745A (en) 2001-01-02 2001-12-18 Peptide compounds
CNA018229107A CN1531546A (en) 2001-01-02 2001-12-18 Peptide compounds
DE60130922T DE60130922T2 (en) 2001-01-02 2001-12-18 Peptides with inhibiting activity for the production of nitric oxide
EP01273184A EP1347990B1 (en) 2001-01-02 2001-12-18 Peptides having inhibiting activity to nitric oxyde production
IL15671101A IL156711A0 (en) 2001-01-02 2001-12-18 Peptide derivatives and pharmaceutical compositions containing the same
CZ20032101A CZ20032101A3 (en) 2001-01-02 2001-12-18 Peptide compounds
NZ527189A NZ527189A (en) 2001-01-02 2001-12-18 Peptide compounds for use in prophylactic and therapeutic treatment of NO-mediated diseases
MXPA03005994A MXPA03005994A (en) 2001-01-02 2001-12-18 Peptide compounds.
US10/250,444 US7129243B2 (en) 2001-01-02 2001-12-18 Peptide compounds
BR0116778-2A BR0116778A (en) 2001-01-02 2001-12-18 Peptide compound, pharmaceutical composition containing the same and its use
PCT/JP2001/011067 WO2002055541A2 (en) 2001-01-02 2001-12-18 Peptides having inhibiting activity on the production of nitric oxide
HU0302535A HUP0302535A3 (en) 2001-01-02 2001-12-18 Peptide compounds, pharmaceutical compositions containing them and their use for treatment of no-mediated diseases
ES01273184T ES2291275T3 (en) 2001-01-02 2001-12-18 PEPTIDES THAT HAVE INHIBITING ACTIVITY OF NITRIC OXIDE PRODUCTION.
JP2002556609A JP4032179B2 (en) 2001-01-02 2001-12-18 Peptides having nitric oxide production inhibitory activity
AT01273184T ATE375360T1 (en) 2001-01-02 2001-12-18 PEPTIDES WITH INHIBITING ACTIVITY FOR THE PRODUCTION OF NITROGEN MONOXIDE
CA2433582A CA2433582C (en) 2001-01-02 2001-12-18 Peptides having inhibiting activity on the production of nitric oxide
ARP010106106A AR034012A1 (en) 2001-01-02 2001-12-28 PEPTIDIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES
NO20032963A NO20032963L (en) 2001-01-02 2003-06-27 peptide
ZA2003/05888A ZA200305888B (en) 2001-01-02 2003-07-30 Peptides having inhibiting activity on the production of nitric oxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR7506A AUPR750601A0 (en) 2001-09-05 2001-09-05 Peptide compounds

Publications (1)

Publication Number Publication Date
AUPR750601A0 true AUPR750601A0 (en) 2001-09-27

Family

ID=3831456

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR7506A Abandoned AUPR750601A0 (en) 2001-01-02 2001-09-05 Peptide compounds

Country Status (1)

Country Link
AU (1) AUPR750601A0 (en)

Similar Documents

Publication Publication Date Title
AU2002349297A1 (en) Statin-like compounds
AU2002359165A1 (en) Novel compounds
PL366425A1 (en) Peptide compounds
AU2002354567A1 (en) Not given
AUPR920301A0 (en) Neurologically-active compounds
AU2002226571A1 (en) Biligands
AU2001100406A4 (en) DriverSMS
AUPR237101A0 (en) Peptide compounds
AUPR750601A0 (en) Peptide compounds
AU2002328853A1 (en) Carcinoma-related peptides
AU2002319429A1 (en) Peptide beta-barrels
AU2002257925A1 (en) Numberplates
AU2004201666B2 (en) 4-Imidazolin-2-one compounds
AU2002230136A1 (en) Peptide derivatives
AU2002226727A1 (en) Peptide derivatives
AU2001100338A4 (en) Sunglove
AU2002100746A4 (en) Adrail
AU2001100522A4 (en) e-Trans
AU2001100532A4 (en) FonePark
AU2001100214A4 (en) Dolly-trolley
AU2002306300A1 (en) Azasugar compounds
AU2002363108A1 (en) 4-imidazolin-2-one compounds
AU2002235881A1 (en) Compounds
AU2002337136A1 (en) Isocyanato-isocyano compounds
AU2002362548A1 (en) **